Home>Stocks>Syngene International Limited
bookmark_border
share

Syngene International

Life Sciences
NaN
NaN (NaN%) 1D
1D
1W
1M
1Y
3Y
5Y
NSE

Fundamentals

Market Cap₹24,042Cr
P/E Ratio66.48
P/B Ratio11.03
Industry P/E106.53
ROE19.89%
EPS(TTM)9.11
Dividend Yield0.09%
Book Value54.87
Understand Fundamentals
info

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly
See Details

About Company

Syngene International Limited is a contract research company. The Company is engaged in providing contract research and manufacturing services in early-stage drug discovery and development to pharmaceutical and biotechnology companies. Its services include discovery chemistry and biology services, toxicology, pharmaceutical development, process development/manufacture of intermediates, active pharmaceutical ingredients and bio-therapeutics. Its services encompass integrated, discovery and development services for novel molecular entities (NMEs) across industrial sectors, including pharmaceutical, biopharmaceutical and biotechnology, among others. It specializes in conducting discovery (from hit to candidate selection), development (including pre-clinical and clinical studies, analytical and bio-analytical evaluation, and stability studies) and manufacturing (scale-up, pre-clinical and manufacturing supplies). It serves clients ranging from multinational corporations to start-ups.
... Read More
Parent OrganisationSyngene International Limited
Founded1993
Managing DirectorMs. Kiran Shaw
NSE SymbolSYNGENE
Introducing Stocks
Investing in stocks will never be the same again
EXPLORE STOCKS
ⓒ 2016-2021 Groww. All rights reserved, Built with in India
ABOUT GROWW
keyboard_arrow_down